Yes, diethylpropion is a Schedule IV controlled substance under the U.S. Controlled Substances Act. This places it in the same legal category as drugs like benzodiazepines and sleep aids, meaning it has a recognized medical use but also carries some potential for abuse and dependence. Prescriptions for diethylpropion are regulated by the DEA, and pharmacies track its dispensing accordingly.
Why It’s Classified as Schedule IV
Diethylpropion is chemically and pharmacologically similar to amphetamines. It works by triggering neurons to release higher levels of dopamine and norepinephrine, the same brain chemicals that amphetamines target. Those elevated levels suppress hunger signals and reduce appetite, which is why the drug is prescribed for weight loss. But that same stimulant activity is also what gives it abuse potential.
Schedule IV is the second-lowest tier of controlled substances (Schedule V being the lowest). Drugs land here when they have a lower risk of dependence compared to Schedule II or III substances but still require monitoring. The DEA’s rationale for diethylpropion specifically cites reports of psychological dependence in some users. That said, the actual number of documented dependence cases has been quite small. The manufacturer of diethylpropion reported only four known cases of dependence or suspected dependence, and in every case, the person had already been dependent on another drug first. This suggests the risk is meaningfully lower than with traditional amphetamines, which sit in the more restrictive Schedule II.
What Diethylpropion Is Prescribed For
Diethylpropion is FDA-approved for short-term management of obesity, specifically described as “a few weeks.” It’s meant as an add-on to a calorie-restricted diet and exercise program, not a standalone treatment. To qualify, a patient typically needs a BMI of 30 or higher and must have already tried losing weight through diet and exercise alone without success. The brand names you may recognize are Tenuate and Tenuate Dospan, though it’s also available as a generic.
Two formulations exist: an immediate-release tablet taken as 25 mg three times daily, and an extended-release 75 mg tablet taken once daily in the midmorning. The extended-release version hasn’t been shown to work better than the immediate-release form at the same total daily dose. It’s simply more convenient.
How Well It Works for Weight Loss
Diethylpropion produces modest weight loss. In pooled study data, patients taking diethylpropion lost an average of about 3.0 kg (roughly 6.6 pounds) more than those on placebo over six months. For comparison, phentermine, another prescription appetite suppressant in the same drug class, produced a slightly larger average loss of 3.6 kg over the same period. In a head-to-head 12-week trial of 99 patients all eating 1,500 calories per day, those on phentermine lost about 2 kg (4.3 pounds) more than those on diethylpropion.
These numbers reflect averages, and individual results vary. But the overall picture is that diethylpropion offers a real but modest boost to weight loss efforts, and it’s somewhat less effective than phentermine, which is the most commonly prescribed short-term appetite suppressant.
Where It Stands in Current Guidelines
Diethylpropion’s FDA approval was based on studies conducted before 1975, and no recent clinical trials meeting modern evidence standards have been published. The 2025 VA/DoD clinical practice guideline for obesity management found insufficient evidence to recommend either for or against using diethylpropion for weight maintenance. It’s not that the drug has been discredited, but rather that the supporting research is decades old and doesn’t meet current expectations for quality. Newer weight loss medications, particularly the GLP-1 receptor agonists, have a far more robust evidence base and have largely shifted clinical attention away from older stimulant-based options.
Common Side Effects
Because diethylpropion is a stimulant, many of its side effects reflect that. The most frequently reported ones include dry mouth, restlessness, insomnia, nervousness, dizziness, and headache. Some people experience digestive issues like nausea, constipation, or diarrhea. Elevated heart rate and increased blood pressure are possible cardiovascular effects.
Less common but more serious reactions include heart rhythm changes, chest pain, and, very rarely, pulmonary hypertension (high blood pressure in the arteries of the lungs). There have been extremely rare reports of heart valve problems associated with diethylpropion, though a direct causal link hasn’t been confirmed. In a small number of people with epilepsy, the drug has been associated with more frequent seizures.
Who Should Not Take It
Diethylpropion is not appropriate for everyone. It should not be used by people with a history of drug abuse, which makes sense given its controlled substance status. Other groups who should avoid it include those with severe high blood pressure, overactive thyroid, glaucoma, advanced hardening of the arteries, or pulmonary hypertension. People in agitated states or those with a known sensitivity to stimulant-type drugs are also excluded.
One critical safety issue: diethylpropion must not be taken within 14 days of using an MAO inhibitor (a type of antidepressant), as the combination can trigger a dangerous spike in blood pressure. It also should not be combined with other appetite suppressants.
Prescription and Legal Practicalities
As a Schedule IV substance, diethylpropion requires a prescription from a licensed provider. Refill rules vary by state, but Schedule IV drugs generally allow up to five refills within six months of the original prescription date. Your pharmacist will keep a record of each fill, and some states may impose additional monitoring requirements. You cannot legally obtain diethylpropion without a prescription, and possessing it without one carries legal consequences that depend on your state’s controlled substance laws.
If you’re prescribed diethylpropion, expect a short treatment window. The FDA label specifies use for only “a few weeks,” and most providers treat it as a temporary tool to help jump-start weight loss rather than a long-term solution.